ResearcherLeiden University Medical CenterNo recent work listed
Babs G. Sibinga Mulder
Matched on ORCID iD 0000-0003-3978-7528; OpenAlex author ID A5081764473. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 8
- Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation S… Co-author DOI 10.2967/jnumed.121.263773↗
- Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Co-author DOI 10.1002/bjs.11115↗
- A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Outcome in Patients with Pancreatic Cancer. Co-author DOI 10.1016/j.ultrasmedbio.2019.04.020↗
- Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infr… Co-author DOI 10.1245/s10434-018-6655-7↗
- Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. First author DOI 10.1245/s10434-018-6705-1↗
- No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study. First author DOI 10.1097/md.0000000000006229↗
- Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer. Co-author DOI 10.1136/jclinpath-2016-203928↗
- Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project. First author DOI 10.1016/j.ejso.2016.03.011↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bert A. Bonsing · 8 shared papers, 2016–2023 · strength 0.67
- Paper Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A M… DOI 10.2967/jnumed.121.263773↗
- Paper A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Ou… DOI 10.1016/j.ultrasmedbio.2019.04.020↗
- Paper Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. DOI 10.1002/bjs.11115↗
- J. Sven D. Mieog · 8 shared papers, 2016–2023 · strength 0.67
- Paper Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A M… DOI 10.2967/jnumed.121.263773↗
- Paper A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Ou… DOI 10.1016/j.ultrasmedbio.2019.04.020↗
- Paper Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. DOI 10.1002/bjs.11115↗
- Alexander L. Vahrmeijer · 5 shared papers, 2017–2023 · strength 0.49
- Paper Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A M… DOI 10.2967/jnumed.121.263773↗
- Paper A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Ou… DOI 10.1016/j.ultrasmedbio.2019.04.020↗
- Paper Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. DOI 10.1002/bjs.11115↗
- Rutger‐Jan Swijnenburg · 4 shared papers, 2017–2019 · strength 0.33
- Paper A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Ou… DOI 10.1016/j.ultrasmedbio.2019.04.020↗
- Paper Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. DOI 10.1002/bjs.11115↗
- Paper Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carci… DOI 10.1245/s10434-018-6655-7↗
- Marjory Koller · 1 shared paper, 2023 · strength 0.17
- Bobby K. Pranger · 1 shared paper, 2023 · strength 0.17
- Vincent Erwin de Meijer · 1 shared paper, 2023 · strength 0.17
- Gooitzen M. van Dam · 1 shared paper, 2023 · strength 0.17
- Jesse V. Groen · 2 shared papers, 2018–2019 · strength 0.16
- Josep Maria Borràs Andrés · 2 shared papers, 2016–2018 · strength 0.12
- Paper Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium. DOI 10.1245/s10434-018-6705-1↗
- Paper Common variables in European pancreatic cancer registries: The introduction of the EURECCA pancreatic cancer project. DOI 10.1016/j.ejso.2016.03.011↗
- Willemieke S. F. J. Tummers · 1 shared paper, 2019 · strength 0.09
- Charlotte E.S. Hoogstins · 1 shared paper, 2018 · strength 0.07
- André Pèlegrin · 1 shared paper, 2018 · strength 0.07
- Giovanni Luigi Capretti · 1 shared paper, 2018 · strength 0.07
- Lydia G. van der Geest · 1 shared paper, 2018 · strength 0.07
- Gerrit‐Jan Liefers · 1 shared paper, 2017 · strength 0.07
- Martine A. Frouws · 1 shared paper, 2017 · strength 0.07
- Hans Morreau · 1 shared paper, 2017 · strength 0.06
- Thomas P. Potjer · 1 shared paper, 2017 · strength 0.06
- Henricus J.M. Handgraaf · 1 shared paper, 2017 · strength 0.06
- Hans F. A. Vasen · 1 shared paper, 2017 · strength 0.06
- Emily Leede · 1 shared paper, 2016 · strength 0.05
- Klaus Sahora · 1 shared paper, 2016 · strength 0.05
- V.E.P.P. Lemmens · 1 shared paper, 2016 · strength 0.05
- Michael Bau Mortensen · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.